Number of the records: 1  

Synthesis and Cytotoxic and Antiviral Activity Profiling of All-Four Isomeric Series of Pyrido-Fused 7-Deazapurine Ribonucleosides

  1. 1.
    SYSNO ASEP0532766
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSynthesis and Cytotoxic and Antiviral Activity Profiling of All-Four Isomeric Series of Pyrido-Fused 7-Deazapurine Ribonucleosides
    Author(s) Veselovská, Lucia (UOCHB-X) ORCID
    Kudlová, N. (CZ)
    Gurská, S. (CZ)
    Lišková, B. (CZ)
    Medvedíková, M. (CZ)
    Hodek, Ondřej (UOCHB-X) ORCID, RID
    Tloušťová, Eva (UOCHB-X) RID, ORCID
    Milisavljevič, Nemanja (UOCHB-X)
    Tichý, Michal (UOCHB-X) RID, ORCID
    Perlíková, Pavla (UOCHB-X) RID, ORCID
    Mertlíková-Kaiserová, Helena (UOCHB-X) RID, ORCID
    Trylčová, Jana (UOCHB-X) ORCID
    Pohl, Radek (UOCHB-X) RID, ORCID
    Klepetářová, Blanka (UOCHB-X) RID, ORCID
    Džubák, P. (CZ)
    Hajdúch, M. (CZ)
    Hocek, Michal (UOCHB-X) RID, ORCID
    Source TitleChemistry - A European Journal. - : Wiley - ISSN 0947-6539
    Roč. 26, č. 57 (2020), s. 13002-13015
    Number of pages14 s.
    Languageeng - English
    CountryDE - Germany
    Keywordsantitumor agents ; antiviral agents ; drug discovery ; phosphorylation ; ribonucleosides
    Subject RIVCC - Organic Chemistry
    OECD categoryOrganic chemistry
    R&D ProjectsGA19-08124S GA ČR - Czech Science Foundation (CSF)
    NV15-31984A GA MZd - Ministry of Health (MZ)
    LM2015064 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingLimited access
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000569396400001
    EID SCOPUS85087796936
    DOI10.1002/chem.202001124
    AnnotationAll four isomeric series of novel 4‐substituted pyrido‐fused 7‐deazapurine ribonucleosides possessing the pyridine nitrogen atom at different positions were designed and synthesized. The total synthesis of each isomeric fused heterocycle through multistep heterocyclization was followed by glycosylation and derivatization at position 4 by cross‐coupling reactions or nucleophilic substitutions. All compounds were tested for cytostatic and antiviral activity. The most active were pyrido[4′,3′:4,5]pyrimidine nucleosides bearing MeO, NH2, MeS, or CH3 groups at position 4, which showed submicromolar cytotoxic effects and good selectivity for cancer cells. The mechanism involved activation by phosphorylation and incorporation to DNA where the presence of the modified ribonucleosides causes double‐strand breaks and apoptosis.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2021
    Electronic addresshttps://doi.org/10.1002/chem.202001124
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.